Invesco · 2021-06-11 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$4.6M | — | — | $72.8M | 每日估算 |
| 2026-07-30 | +$1.6M | — | — | $76.7M | 每日估算 |
| 2026-07-29 | +$194,528 | — | — | $75.9M | 每日估算 |
| 2026-07-28 | +$1.8M | — | — | $74.9M | 每日估算 |
| 2026-07-27 | +$396,806 | — | — | $72.8M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Invesco Private Prime Fund Invesco Private Prime Fund | STIV | 10,825,717 | $10.8M | 14.29% |
Gilead Sciences, Inc. Gilead Sciences, Inc. | EC | 48,865 | $7.3M | 9.61% |
Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. | EC | 14,178 | $7.0M | 9.30% |
Amgen Inc. Amgen Inc. |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$1.8M | — | — | $72.8M | 每日估算 |
| 2026-07-25 | +$408,871 | — | — | $75.0M | 每日估算 |
| 2026-02-28 | +$294,071 | $2.1M | $1.8M | $75.7M | SEC 月度 |
| 2026-01-31 | +$7.6M | $15.1M | $7.5M | — | SEC 月度 |
| 2025-12-31 | +$5.7M | $5.7M | $0 | — | SEC 月度 |
| EC |
| 17,796 |
| $6.9M |
| 9.12% |
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. | EC | 5,839 | $4.6M | 6.03% |
Invesco Private Government Fund Invesco Private Government Fund | STIV | 4,201,477 | $4.2M | 5.55% |
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. | EC | 7,470 | $2.5M | 3.28% |
Insmed Inc. Insmed Inc. | EC | 12,065 | $1.8M | 2.38% |
Biogen Inc. Biogen Inc. | EC | 8,295 | $1.6M | 2.10% |
argenx SE, ADR argenx SE, ADR | EC | 1,648 | $1.3M | 1.67% |
United Therapeutics Corp. United Therapeutics Corp. | EC | 2,437 | $1.2M | 1.62% |
Moderna, Inc. Moderna, Inc. | EC | 22,109 | $1.2M | 1.56% |
Illumina, Inc. Illumina, Inc. | EC | 8,646 | $1.2M | 1.53% |
Roivant Sciences Ltd. Roivant Sciences Ltd. | EC | 39,369 | $1.1M | 1.50% |
Incyte Corp. Incyte Corp. | EC | 11,115 | $1.1M | 1.49% |
Royalty Pharma PLC, Class A Royalty Pharma PLC, Class A | EC | 24,171 | $1.1M | 1.47% |
Revolution Medicines, Inc. Revolution Medicines, Inc. | EC | 10,938 | $1.1M | 1.47% |
Viatris Inc. Viatris Inc. | EC | 65,178 | $973,108 | 1.28% |
Ascendis Pharma A/S, ADR Ascendis Pharma A/S, ADR | EC | 3,474 | $811,179 | 1.07% |
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. | EC | 5,641 | $746,022 | 0.98% |
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. | EC | 9,163 | $743,577 | 0.98% |
Sanofi, ADR Sanofi, ADR | EC | 14,988 | $729,316 | 0.96% |
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. | EC | 10,918 | $725,829 | 0.96% |
Medpace Holdings, Inc. Medpace Holdings, Inc. | EC | 1,593 | $719,654 | 0.95% |
Summit Therapeutics Inc. Summit Therapeutics Inc. | EC | 42,174 | $699,667 | 0.92% |
Guardant Health, Inc. Guardant Health, Inc. | EC | 7,319 | $687,254 | 0.91% |
BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. | EC | 10,885 | $671,931 | 0.89% |
Exelixis, Inc. Exelixis, Inc. | EC | 15,175 | $668,611 | 0.88% |
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC | EC | 3,442 | $654,049 | 0.86% |
BioNTech SE, ADR BioNTech SE, ADR | EC | 5,726 | $631,177 | 0.83% |
BeOne Medicines Ltd., ADR BeOne Medicines Ltd., ADR | EC | 1,784 | $565,510 | 0.75% |
Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc. | EC | 1,287 | $555,984 | 0.73% |
ImmunityBio, Inc. ImmunityBio, Inc. | EC | 55,881 | $546,516 | 0.72% |
Tempus AI, Inc., Class A Tempus AI, Inc., Class A | EC | 9,809 | $522,329 | 0.69% |
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. | EC | 7,676 | $485,661 | 0.64% |
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. | EC | 1,420 | $478,185 | 0.63% |
Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. | EC | 2,849 | $466,923 | 0.62% |
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. | EC | 6,671 | $463,835 | 0.61% |
Vaxcyte, Inc. Vaxcyte, Inc. | EC | 7,425 | $458,420 | 0.61% |
Krystal Biotech, Inc. Krystal Biotech, Inc. | EC | 1,646 | $453,703 | 0.60% |
Cytokinetics, Inc. Cytokinetics, Inc. | EC | 6,884 | $428,322 | 0.57% |
Nuvalent, Inc., Class A Nuvalent, Inc., Class A | EC | 4,101 | $418,097 | 0.55% |
Abivax S.A., ADR Abivax S.A., ADR | EC | 3,337 | $404,711 | 0.53% |
Arcellx, Inc. Arcellx, Inc. | EC | 3,276 | $372,776 | 0.49% |
Kymera Therapeutics, Inc. Kymera Therapeutics, Inc. | EC | 4,067 | $371,520 | 0.49% |
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals, Inc. | EC | 3,774 | $349,963 | 0.46% |
Cogent Biosciences, Inc. Cogent Biosciences, Inc. | EC | 8,738 | $339,471 | 0.45% |
Protagonist Therapeutics, Inc. Protagonist Therapeutics, Inc. | EC | 3,560 | $327,805 | 0.43% |
CRISPR Therapeutics AG CRISPR Therapeutics AG | EC | 5,417 | $325,778 | 0.43% |
Caris Life Sciences, Inc. Caris Life Sciences, Inc. | EC | 15,855 | $319,320 | 0.42% |
PTC Therapeutics, Inc. PTC Therapeutics, Inc. | EC | 4,553 | $310,469 | 0.41% |
Alkermes PLC Alkermes PLC | EC | 9,274 | $279,147 | 0.37% |
Immunovant, Inc. Immunovant, Inc. | EC | 9,812 | $272,087 | 0.36% |
CG Oncology, Inc. CG Oncology, Inc. | EC | 4,605 | $270,774 | 0.36% |
Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. | EC | 2,923 | $269,764 | 0.36% |
Scholar Rock Holding Corp. Scholar Rock Holding Corp. | EC | 5,710 | $252,782 | 0.33% |
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. | EC | 17,240 | $247,739 | 0.33% |
Amneal Pharmaceuticals, Inc. Amneal Pharmaceuticals, Inc. | EC | 17,835 | $246,301 | 0.33% |
Structure Therapeutics Inc., ADR Structure Therapeutics Inc., ADR | EC | 3,736 | $235,293 | 0.31% |
Acadia Pharmaceuticals Inc. Acadia Pharmaceuticals Inc. | EC | 9,567 | $234,966 | 0.31% |
Indivior Pharmaceuticals, Inc. Indivior Pharmaceuticals, Inc. | EC | 6,991 | $228,746 | 0.30% |
NewAmsterdam Pharma Co. N.V. NewAmsterdam Pharma Co. N.V. | EC | 6,442 | $228,433 | 0.30% |
Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc. | EC | 5,407 | $222,228 | 0.29% |
Ligand Pharmaceuticals Inc. Ligand Pharmaceuticals Inc. | EC | 1,101 | $218,339 | 0.29% |
Erasca, Inc. Erasca, Inc. | EC | 15,831 | $216,251 | 0.29% |
Apogee Therapeutics, Inc. Apogee Therapeutics, Inc. | EC | 3,075 | $215,250 | 0.28% |
Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc. | EC | 5,023 | $211,569 | 0.28% |
ADMA Biologics, Inc. ADMA Biologics, Inc. | EC | 13,305 | $207,159 | 0.27% |
Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals Inc. | EC | 4,390 | $189,780 | 0.25% |
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. | EC | 4,352 | $187,180 | 0.25% |
Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. | EC | 6,836 | $184,367 | 0.24% |
Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc. | EC | 5,934 | $180,631 | 0.24% |
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. | EC | 2,367 | $178,756 | 0.24% |
Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals, Inc. | EC | 3,195 | $174,862 | 0.23% |
Denali Therapeutics Inc. Denali Therapeutics Inc. | EC | 8,178 | $173,210 | 0.23% |
Veracyte, Inc. Veracyte, Inc. | EC | 4,424 | $161,874 | 0.21% |
Beam Therapeutics Inc. Beam Therapeutics Inc. | EC | 5,686 | $161,824 | 0.21% |
Alumis Inc. Alumis Inc. | EC | 5,443 | $161,603 | 0.21% |
Twist Bioscience Corp. Twist Bioscience Corp. | EC | 3,416 | $160,279 | 0.21% |
IDEAYA Biosciences, Inc. IDEAYA Biosciences, Inc. | EC | 4,907 | $158,005 | 0.21% |
10x Genomics, Inc., Class A 10x Genomics, Inc., Class A | EC | 6,513 | $150,125 | 0.20% |
Travere Therapeutics, Inc. Travere Therapeutics, Inc. | EC | 4,995 | $148,801 | 0.20% |
Apellis Pharmaceuticals, Inc. Apellis Pharmaceuticals, Inc. | EC | 7,068 | $148,145 | 0.20% |
Vera Therapeutics, Inc. Vera Therapeutics, Inc. | EC | 3,585 | $146,232 | 0.19% |
Centessa Pharmaceuticals PLC, ADR Centessa Pharmaceuticals PLC, ADR | EC | 5,405 | $145,178 | 0.19% |
Disc Medicine, Inc. Disc Medicine, Inc. | EC | 2,105 | $140,235 | 0.19% |
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. | EC | 8,546 | $136,907 | 0.18% |
Wave Life Sciences Ltd. Wave Life Sciences Ltd. | EC | 9,352 | $130,273 | 0.17% |
Mineralys Therapeutics, Inc. Mineralys Therapeutics, Inc. | EC | 4,428 | $129,563 | 0.17% |
Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceutical Inc. | EC | 5,405 | $126,423 | 0.17% |
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc. | EC | 7,965 | $124,413 | 0.16% |
Maze Therapeutics, Inc. Maze Therapeutics, Inc. | EC | 2,678 | $122,090 | 0.16% |
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. | EC | 3,184 | $115,929 | 0.15% |
GRAIL, Inc. GRAIL, Inc. | EC | 2,176 | $115,828 | 0.15% |
Kiniksa Pharmaceuticals International, PLC Kiniksa Pharmaceuticals International, PLC | EC | 2,538 | $112,916 | 0.15% |
Harrow, Inc. Harrow, Inc. | EC | 2,072 | $112,261 | 0.15% |
Olema Pharmaceuticals, Inc. Olema Pharmaceuticals, Inc. | EC | 4,401 | $106,504 | 0.14% |
Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. | EC | 11,885 | $106,252 | 0.14% |
Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticals, Inc. | EC | 4,873 | $105,793 | 0.14% |
Recursion Pharmaceuticals, Inc., Class A Recursion Pharmaceuticals, Inc., Class A | EC | 28,735 | $105,457 | 0.14% |
Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc. | EC | 7,358 | $104,263 | 0.14% |
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. | EC | 11,766 | $102,953 | 0.14% |
Pharvaris N.V. Pharvaris N.V. | EC | 3,591 | $101,948 | 0.13% |
Vericel Corp. Vericel Corp. | EC | 2,833 | $101,081 | 0.13% |
Relay Therapeutics, Inc. Relay Therapeutics, Inc. | EC | 9,680 | $99,317 | 0.13% |
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. | EC | 3,328 | $98,808 | 0.13% |
Tyra Biosciences, Inc. Tyra Biosciences, Inc. | EC | 2,966 | $98,797 | 0.13% |
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. | EC | 3,239 | $97,915 | 0.13% |
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. | EC | 5,837 | $97,828 | 0.13% |
Zymeworks Inc. Zymeworks Inc. | EC | 4,184 | $97,445 | 0.13% |
Definium Therapeutics, Inc. Definium Therapeutics, Inc. | EC | 5,503 | $96,027 | 0.13% |
Innoviva, Inc. Innoviva, Inc. | EC | 4,181 | $95,996 | 0.13% |
Genmab A/S, ADR Genmab A/S, ADR | EC | 3,245 | $95,533 | 0.13% |
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. | EC | 1,263 | $93,336 | 0.12% |
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. | EC | 6,115 | $92,765 | 0.12% |
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. | EC | 2,692 | $92,632 | 0.12% |
Novavax, Inc. Novavax, Inc. | EC | 9,091 | $92,183 | 0.12% |
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. | EC | 2,514 | $91,862 | 0.12% |
Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. | EC | 3,206 | $91,499 | 0.12% |
Nurix Therapeutics, Inc. Nurix Therapeutics, Inc. | EC | 5,681 | $90,726 | 0.12% |
RAPT Therapeutics, Inc. RAPT Therapeutics, Inc. | EC | 1,551 | $89,927 | 0.12% |
Legend Biotech Corp., ADR Legend Biotech Corp., ADR | EC | 4,707 | $89,433 | 0.12% |
Ardelyx, Inc. Ardelyx, Inc. | EC | 13,580 | $88,949 | 0.12% |
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. | EC | 6,453 | $88,922 | 0.12% |
NovoCure Ltd. NovoCure Ltd. | EC | 6,261 | $85,588 | 0.11% |
AnaptysBio, Inc. AnaptysBio, Inc. | EC | 1,550 | $85,328 | 0.11% |
Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. | EC | 22,091 | $85,271 | 0.11% |
Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. | EC | 7,146 | $85,180 | 0.11% |
Tango Therapeutics Inc. Tango Therapeutics Inc. | EC | 7,535 | $83,940 | 0.11% |
MBX Biosciences, Inc. MBX Biosciences, Inc. | EC | 2,526 | $82,221 | 0.11% |
EyePoint, Inc. EyePoint, Inc. | EC | 4,637 | $81,426 | 0.11% |
Kodiak Sciences Inc. Kodiak Sciences Inc. | EC | 2,951 | $79,087 | 0.10% |
Immunocore Holdings PLC, ADR Immunocore Holdings PLC, ADR | EC | 2,432 | $78,554 | 0.10% |
Zenas Biopharma, Inc. Zenas Biopharma, Inc. | EC | 2,980 | $78,523 | 0.10% |
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. | EC | 2,657 | $77,133 | 0.10% |
Corvus Pharmaceuticals, Inc. Corvus Pharmaceuticals, Inc. | EC | 4,177 | $76,272 | 0.10% |
Precigen, Inc. Precigen, Inc. | EC | 19,747 | $74,841 | 0.10% |
Collegium Pharmaceutical, Inc. Collegium Pharmaceutical, Inc. | EC | 1,776 | $74,006 | 0.10% |
AtaiBeckley Inc. AtaiBeckley Inc. | EC | 20,269 | $73,576 | 0.10% |
ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals, Inc. | EC | 5,451 | $73,316 | 0.10% |
Septerna, Inc. Septerna, Inc. | EC | 2,520 | $73,130 | 0.10% |
Vir Biotechnology, Inc. Vir Biotechnology, Inc. | EC | 7,785 | $70,766 | 0.09% |
Alvotech Alvotech | EC | 17,492 | $69,793 | 0.09% |
Taysha Gene Therapies Inc. Taysha Gene Therapies Inc. | EC | 15,289 | $69,259 | 0.09% |
Savara Inc. Savara Inc. | EC | 11,348 | $68,315 | 0.09% |
Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics, Inc. | EC | 3,640 | $64,610 | 0.09% |
Sana Biotechnology, Inc. Sana Biotechnology, Inc. | EC | 14,886 | $62,670 | 0.08% |
Grifols, S.A., ADR Grifols, S.A., ADR | EC | 6,813 | $61,998 | 0.08% |
Phibro Animal Health Corp., Class A Phibro Animal Health Corp., Class A | EC | 1,124 | $61,359 | 0.08% |
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc. | EC | 5,740 | $60,844 | 0.08% |
AbCellera Biologics Inc. AbCellera Biologics Inc. | EC | 16,724 | $60,374 | 0.08% |
Geron Corp. Geron Corp. | EC | 35,647 | $59,887 | 0.08% |
Inhibrx Biosciences, Inc. Inhibrx Biosciences, Inc. | EC | 807 | $59,823 | 0.08% |
UroGen Pharma Ltd. UroGen Pharma Ltd. | EC | 2,613 | $56,702 | 0.07% |
Xeris Biopharma Holdings, Inc. Xeris Biopharma Holdings, Inc. | EC | 9,253 | $56,628 | 0.07% |
MannKind Corp. MannKind Corp. | EC | 17,136 | $56,206 | 0.07% |
Ventyx Biosciences, Inc. Ventyx Biosciences, Inc. | EC | 3,977 | $55,559 | 0.07% |
Fortrea Holdings Inc. Fortrea Holdings Inc. | EC | 5,176 | $55,487 | 0.07% |
uniQure N.V. uniQure N.V. | EC | 3,468 | $54,205 | 0.07% |
ArriVent Biopharma, Inc. ArriVent Biopharma, Inc. | EC | 2,313 | $53,130 | 0.07% |
Pacira Biosciences, Inc. Pacira Biosciences, Inc. | EC | 2,398 | $52,540 | 0.07% |
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. | EC | 2,574 | $52,072 | 0.07% |
Theravance Biopharma Inc. Theravance Biopharma Inc. | EC | 2,837 | $51,775 | 0.07% |
Bicara Therapeutics Inc. Bicara Therapeutics Inc. | EC | 3,072 | $51,548 | 0.07% |
Cullinan Therapeutics, Inc. Cullinan Therapeutics, Inc. | EC | 3,316 | $51,398 | 0.07% |
GH Research PLC GH Research PLC | EC | 3,456 | $51,322 | 0.07% |
ARS Pharmaceuticals, Inc. ARS Pharmaceuticals, Inc. | EC | 5,518 | $51,207 | 0.07% |
Xencor, Inc. Xencor, Inc. | EC | 3,980 | $50,825 | 0.07% |
CytomX Therapeutics, Inc. CytomX Therapeutics, Inc. | EC | 9,460 | $50,800 | 0.07% |
Arbutus Biopharma Corp. Arbutus Biopharma Corp. | EC | 10,743 | $50,062 | 0.07% |
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals, Inc. | EC | 3,967 | $49,826 | 0.07% |
Castle Biosciences, Inc. Castle Biosciences, Inc. | EC | 1,619 | $47,874 | 0.06% |
Arvinas, Inc. Arvinas, Inc. | EC | 3,599 | $47,759 | 0.06% |
Omeros Corp. Omeros Corp. | EC | 3,957 | $47,682 | 0.06% |
Prime Medicine, Inc. Prime Medicine, Inc. | EC | 10,067 | $46,510 | 0.06% |
KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc. | EC | 2,831 | $46,089 | 0.06% |
Janux Therapeutics, Inc. Janux Therapeutics, Inc. | EC | 3,365 | $45,798 | 0.06% |
Annexon, Inc. Annexon, Inc. | EC | 8,089 | $45,298 | 0.06% |
Personalis, Inc. Personalis, Inc. | EC | 4,964 | $44,974 | 0.06% |
BioAge Labs, Inc. BioAge Labs, Inc. | EC | 2,018 | $44,941 | 0.06% |
Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. | EC | 13,354 | $44,736 | 0.06% |
Mesoblast Ltd., ADR Mesoblast Ltd., ADR | EC | 2,721 | $43,128 | 0.06% |
Kura Oncology, Inc. Kura Oncology, Inc. | EC | 4,878 | $42,585 | 0.06% |
Zai Lab Ltd., ADR Zai Lab Ltd., ADR | EC | 2,174 | $41,784 | 0.06% |
Invesco Government & Agency Portfolio, Institutional Class Invesco Government & Agency Portfolio, Institutional Class | STIV | 39,488 | $39,488 | 0.05% |
COMPASS Pathways PLC, ADR COMPASS Pathways PLC, ADR | EC | 5,259 | $36,287 | 0.05% |
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. | EC | 1,019 | $35,400 | 0.05% |
Allogene Therapeutics, Inc. Allogene Therapeutics, Inc. | EC | 12,556 | $34,906 | 0.05% |
MeiraGTx Holdings PLC MeiraGTx Holdings PLC | EC | 4,490 | $33,944 | 0.04% |
Replimune Group, Inc. Replimune Group, Inc. | EC | 4,391 | $33,591 | 0.04% |
Design Therapeutics, Inc. Design Therapeutics, Inc. | EC | 3,177 | $33,168 | 0.04% |
Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. | EC | 9,348 | $32,625 | 0.04% |
CorMedix Inc. CorMedix Inc. | EC | 4,414 | $31,472 | 0.04% |
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. | EC | 9,099 | $31,119 | 0.04% |
4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics, Inc. | EC | 3,185 | $30,767 | 0.04% |
Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc. | EC | 6,041 | $30,265 | 0.04% |
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc. | EC | 3,317 | $29,554 | 0.04% |
Lexeo Therapeutics, Inc. Lexeo Therapeutics, Inc. | EC | 4,094 | $29,395 | 0.04% |
Lyell Immunopharma, Inc. Lyell Immunopharma, Inc. | EC | 1,207 | $28,968 | 0.04% |
Maravai LifeSciences Holdings, Inc., Class A Maravai LifeSciences Holdings, Inc., Class A | EC | 8,103 | $28,847 | 0.04% |
Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. | EC | 16,852 | $28,311 | 0.04% |
Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. | EC | 3,142 | $28,058 | 0.04% |
Kamada Ltd. Kamada Ltd. | EC | 3,210 | $27,927 | 0.04% |
Aquestive Therapeutics, Inc. Aquestive Therapeutics, Inc. | EC | 6,813 | $27,252 | 0.04% |
Solid Biosciences Inc. Solid Biosciences Inc. | EC | 4,366 | $27,113 | 0.04% |
Galapagos N.V., ADR Galapagos N.V., ADR | EC | 803 | $27,029 | 0.04% |
Invivyd, Inc. Invivyd, Inc. | EC | 15,472 | $26,148 | 0.03% |
Prothena Corp. PLC Prothena Corp. PLC | EC | 2,992 | $25,941 | 0.03% |
SIGA Technologies, Inc. SIGA Technologies, Inc. | EC | 3,989 | $25,809 | 0.03% |
Eton Pharmaceuticals, Inc. Eton Pharmaceuticals, Inc. | EC | 1,510 | $25,655 | 0.03% |
REGENXBIO Inc. REGENXBIO Inc. | EC | 2,835 | $25,628 | 0.03% |
Fulcrum Therapeutics, Inc. Fulcrum Therapeutics, Inc. | EC | 3,042 | $25,492 | 0.03% |
Entrada Therapeutics, Inc. Entrada Therapeutics, Inc. | EC | 2,126 | $25,363 | 0.03% |
Larimar Therapeutics, Inc. Larimar Therapeutics, Inc. | EC | 4,770 | $25,329 | 0.03% |
Altimmune, Inc. Altimmune, Inc. | EC | 5,817 | $25,071 | 0.03% |
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. | EC | 1,045 | $24,505 | 0.03% |
Keros Therapeutics, Inc. Keros Therapeutics, Inc. | EC | 1,724 | $24,464 | 0.03% |
PepGen Inc. PepGen Inc. | EC | 3,853 | $23,966 | 0.03% |
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. | EC | 1,768 | $23,850 | 0.03% |
Upstream Bio, Inc. Upstream Bio, Inc. | EC | 3,038 | $23,332 | 0.03% |
AbSci Corp. AbSci Corp. | EC | 8,394 | $23,000 | 0.03% |
Enanta Pharmaceuticals, Inc. Enanta Pharmaceuticals, Inc. | EC | 1,604 | $22,937 | 0.03% |
Anavex Life Sciences Corp. Anavex Life Sciences Corp. | EC | 4,989 | $22,101 | 0.03% |
Aura Biosciences, Inc. Aura Biosciences, Inc. | EC | 3,566 | $21,004 | 0.03% |
Atea Pharmaceuticals, Inc. Atea Pharmaceuticals, Inc. | EC | 4,376 | $20,480 | 0.03% |
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. | EC | 2,433 | $19,975 | 0.03% |
Neurogene Inc. Neurogene Inc. | EC | 848 | $19,920 | 0.03% |
Contineum Therapeutics, Inc., Class A Contineum Therapeutics, Inc., Class A | EC | 1,293 | $19,835 | 0.03% |
Autolus Therapeutics PLC, ADR Autolus Therapeutics PLC, ADR | EC | 11,218 | $19,183 | 0.03% |
NovaBridge Biosciences, ADR NovaBridge Biosciences, ADR | EC | 5,799 | $19,021 | 0.03% |
Immuneering Corp., Class A Immuneering Corp., Class A | EC | 3,615 | $18,039 | 0.02% |
Foghorn Therapeutics Inc. Foghorn Therapeutics Inc. | EC | 3,158 | $17,937 | 0.02% |
Cabaletta Bio, Inc. Cabaletta Bio, Inc. | EC | 5,395 | $17,911 | 0.02% |
Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. | EC | 6,047 | $17,355 | 0.02% |
AC Immune S.A. AC Immune S.A. | EC | 5,590 | $16,379 | 0.02% |
Candel Therapeutics, Inc. Candel Therapeutics, Inc. | EC | 3,078 | $16,160 | 0.02% |
Puma Biotechnology, Inc. Puma Biotechnology, Inc. | EC | 2,824 | $16,097 | 0.02% |
Evolus, Inc. Evolus, Inc. | EC | 3,626 | $15,592 | 0.02% |
Aardvark Therapeutics, Inc. Aardvark Therapeutics, Inc. | EC | 1,232 | $15,388 | 0.02% |
Lifecore Biomedical, Inc. Lifecore Biomedical, Inc. | EC | 2,092 | $15,062 | 0.02% |
Bicycle Therapeutics PLC, ADR Bicycle Therapeutics PLC, ADR | EC | 2,589 | $14,835 | 0.02% |
Vor BioPharma Inc. Vor BioPharma Inc. | EC | 960 | $14,822 | 0.02% |
C4 Therapeutics, Inc. C4 Therapeutics, Inc. | EC | 5,430 | $14,661 | 0.02% |
Silence Therapeutics PLC, ADR Silence Therapeutics PLC, ADR | EC | 2,621 | $14,258 | 0.02% |
OmniAb, Inc. OmniAb, Inc. | EC | 8,054 | $13,853 | 0.02% |
Orchestra Biomed Holdings, Inc. Orchestra Biomed Holdings, Inc. | EC | 3,155 | $13,819 | 0.02% |
Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings Inc. | EC | 1,610 | $13,250 | 0.02% |
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc. | EC | 3,162 | $12,964 | 0.02% |
Humacyte, Inc. Humacyte, Inc. | EC | 10,465 | $11,668 | 0.02% |
Editas Medicine, Inc. Editas Medicine, Inc. | EC | 5,197 | $11,433 | 0.02% |